Skip to main content
TipRanks
Go Ultimate75% OFF

Unicharm (UNICY) AI Stock Analysis

17 Followers
UNICY

Unicharm

(Other OTC:UNICY)

Select Model
Rating:71Outperform
Price Target:$4.00â–²(9.98% Upside)
Action:reiterated
Date:11/13/26

Robust balance sheet and bullish technical momentum are the primary drivers, while margin pressures and premium valuation limit further upside.

Positive Factors
Very low leverageMinimal debt and steadily rising equity give Unicharm substantial financial resilience. The conservative capital structure limits interest and refinancing pressure, preserves flexibility to invest in brands and capacity, and improves its ability to withstand weaker operating conditions over the next several quarters.
Negative Factors
Flat recent revenueLimited recent top-line growth indicates that the company’s established categories and regional operations are not currently translating into meaningful revenue expansion. Prolonged stagnation could constrain operating leverage and make future earnings improvement more dependent on pricing or cost control.

Unicharm (UNICY) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%25%UNICY+24.64%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$12.25B
Dividend Yield
1.75%
Average Volume (3M)
130.53K
Price to Earnings (P/E)
32.6
Beta (1Y)
0.04
Revenue Growth
-3.29%
EPS Growth
-29.12%
Country
US
Employees
16,542
Sector
Consumer Defensive
Sector Strength
62
Industry
Household & Personal Products

Unicharm Business Overview & Revenue Model

Company Description

Unicharm Corporation, founded in Tokyo, Japan, in 1941, operates as a global enterprise engaged in the manufacturing and distribution of a wide array of consumer and industrial products. Its diverse offerings span several major categories: The baby a...

How the Company Makes Money

Unicharm primarily makes money by selling branded disposable hygiene and personal care products to retailers, wholesalers, and other distribution partners (and in some markets directly via e-commerce), generating revenue at the point of product shipm...

Unicharm Earnings Call Summary

Earnings Call Date:Aug 05, 2025(Q2-2025)|% Change Since:1.56%|Next Earnings Date:Feb 18, 2027
Earnings Call SentimentNeutral

The earnings call presented a mixed picture with notable achievements in Japan and North America, and strategic shareholder returns. However, significant challenges were highlighted, particularly in Asia, with declining sales and profitability leading to a downward revision of the earnings forecast.

Positive Updates

Japan's Record Performance
Japan achieved a 4.1% increase in net sales and a 2.9% increase in core operating income, the highest results ever recorded, driven by new product success and an improved sales mix in wellness and pet care.

Negative Updates

Sales and Core Operating Income Decline
Consolidated sales fell by 4.8% to 464.2 billion, and core operating income decreased by 22% to JPY57 billion, primarily due to strong performance in the previous year and reputational incidents in China.

Company Guidance

In the call, Unicharm Corporation reported a 4.8% decline in sales to JPY464.2 billion and a 22% decrease in core operating income to JPY57 billion for the second quarter of fiscal year 2025. This decline was primarily attributed to a reaction to the previous year's record-high profits and reputational issues in the feminine care segment in China. The Asian market faced competitive pressures, and strategic marketing and sales promotions further impacted earnings. However, interim income attributable to the parent company increased due to JPY5.3 billion in insurance income from India and the utilization of tax loss carryforwards. The Japan business achieved a 4.1% increase in net sales and a 2.9% increase in core operating income, marking its highest results ever recorded. Despite challenges in Asia, signs of recovery are emerging, particularly in Vietnam, and strategic investments in growth channels are expected to yield positive results from the third quarter onward. Additionally, the fiscal year forecast was revised downward due to slower recovery in Asia, while regions like Japan, North America, and the Middle East performed better than expected. The company is also committed to shareholder returns, targeting a total return ratio of 50% or more.

Unicharm Financial Statement Overview

Summary

Exceptionally strong balance sheet with near-zero leverage offsets margin compression and flat revenue growth in the income statement, with reliable cash flows providing support.

Income Statement

46Neutral

Balance Sheet

93Very Positive

Cash Flow

67Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue989.22B991.09B988.98B941.79B898.02B782.72B
Gross Profit387.48B373.10B389.91B351.53B328.60B313.64B
EBITDA166.11B164.29B185.00B180.56B161.16B160.80B
Net Income61.67B68.37B81.84B86.05B67.61B72.75B
Balance Sheet
Total Assets1.22T1.22T1.24T1.13T1.05T987.65B
Cash, Cash Equivalents and Short-Term Investments233.96B253.26B353.94B253.77B307.60B307.30B
Total Debt14.66B11.06B26.85B28.57B27.02B38.31B
Total Liabilities318.52B332.14B366.26B345.38B340.61B352.22B
Stockholders Equity800.92B795.25B773.06B695.72B618.88B557.64B
Cash Flow
Free Cash Flow99.56B107.83B97.77B124.00B59.27B70.58B
Operating Cash Flow121.47B137.84B137.10B162.41B92.22B105.25B
Investing Cash Flow-47.45B-58.65B-73.84B-67.53B-7.14B-79.84B
Financing Cash Flow-72.57B-90.84B-66.79B-67.01B-61.65B-45.18B

Unicharm Technical Analysis

Technical Analysis SentimentPositive
Last Price3.64

Price Trends

50DMA3.17Positive
100DMA3.12Positive
200DMA3.06Positive

Market Momentum

MACD0.12Negative
RSI71.91Negative
STOCH100.19Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UNICY, the sentiment is Positive. The current price of 3.64 is above the 20-day moving average (MA) of 3.33, above the 50-day MA of 3.17, and above the 200-day MA of 3.06, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 71.91 is Negative, neither overbought nor oversold. The STOCH value of 100.19 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UNICY.

Unicharm Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

UNICY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
PGPG72Outperform$398.01B25.4329.55%2.52%3.52%-3.74%
UNICYUNICY71Outperform$13.28B32.637.69%1.75%-3.29%-29.12%
KMBKMB69Neutral$66.37B10.88162.62%4.72%-8.38%67.47%
HNSTHNST64Neutral$509.97M6.4240.79%―-12.81%1040.88%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
EPCEPC51Neutral$1.29B-25.22-3.53%2.15%-10.21%-310.40%

* Consumer Defensive Sector Average

Performance Comparison

0%50%100%UNICYKMBPGEPCHNSTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
UNICY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
UNICYUnicharm Corporation Sponsored ADR3.640.6923.37%
KMBKimberly Clark108.1510.7711.06%
PGProcter & Gamble Company171.7228.8820.21%
EPCEdgewell Personal Care Co27.9711.0365.09%
HNSTHonest Company, Inc.4.672.0679.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026